Clinical Trial Update: Clinical Trial to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years Old. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring skin test dosage of EEC for tuberculosis and assessing safety and preliminary efficacy across a wide age range.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• EEC

Snippet

Sponsor: Chengdu CoenBiotech Co., Ltd | Conditions: Tuberculosis | Phase 2 | Status: UNKNOWN